New biologic drug aims to ease pain in hidden arthritis
NCT ID NCT03928704
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This phase 3 study tested the drug bimekizumab against a placebo in 274 adults with active nonradiographic axial spondyloarthritis, a form of arthritis that causes back pain but doesn't appear on X-rays. Participants received injections of either the drug or a placebo over several weeks. The main goal was to see if bimekizumab could reduce disease activity and improve symptoms like pain and stiffness.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
bimekizumab (a biologic drug given as an injection)
What this could lead to
If it works, this could provide a new treatment option to reduce pain and improve function in people with this type of arthritis.
What could go wrong
This is a single phase 3 trial; results may not confirm benefit or may show side effects. The drug is not yet approved for this condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NONRADIOGRAPHIC AXIAL SPONDYLOARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
As0010 20018
Shanghai, China
-
As0010 20019
Guangzhou, China
-
As0010 20020
Shanghai, China
-
As0010 20021
Chengdu, China
-
As0010 20024
Nanjing, China
-
As0010 20025
Wenzhou, China
-
As0010 20026
Shanghai, China
-
As0010 20030
Chūōku, Japan
-
As0010 20031
Sapporo, Japan
-
As0010 20034
Hefei, China
-
As0010 20035
Tokyo, Japan
-
As0010 20036
Kawachi-Nagano, Japan
-
As0010 20037
Osaka, Japan
-
As0010 20038
Nankoku-shi, Japan
-
As0010 20039
Iruma-gun, Japan
-
As0010 20040
Beijing, China
-
As0010 20045
Kita-gun, Japan
-
As0010 20048
Saitama, Japan
-
As0010 20065
Kitakyushu, Japan
-
As0010 20084
Saga, Japan
-
As0010 40001
Ghent, Belgium
-
As0010 40002
Merksem, Belgium
-
As0010 40003
Genk, Belgium
-
As0010 40004
Brussels, Belgium
-
As0010 40005
Sofia, Bulgaria
-
As0010 40006
Plovdiv, Bulgaria
-
As0010 40007
Plovdiv, Bulgaria
-
As0010 40008
Sofia, Bulgaria
-
As0010 40009
Pardubice, Czechia
-
As0010 40010
Uherské Hradiště, Czechia
-
As0010 40011
Brno, Czechia
-
As0010 40012
Zlín, Czechia
-
As0010 40013
Prague, Czechia
-
As0010 40014
Prague, Czechia
-
As0010 40015
Prague, Czechia
-
As0010 40016
Prague, Czechia
-
As0010 40018
Boulogne-Billancourt, France
-
As0010 40022
Limoges, France
-
As0010 40024
Hanover, Germany
-
As0010 40025
Berlin, Germany
-
As0010 40026
Ratingen, Germany
-
As0010 40027
Herne, Germany
-
As0010 40029
Hamburg, Germany
-
As0010 40031
Szeged, Hungary
-
As0010 40032
Debrecen, Hungary
-
As0010 40033
Székesfehérvár, Hungary
-
As0010 40037
Lublin, Poland
-
As0010 40038
Elblag, Poland
-
As0010 40039
Wroclaw, Poland
-
As0010 40040
Torun, Poland
-
As0010 40041
Warsaw, Poland
-
As0010 40042
Krakow, Poland
-
As0010 40043
Wroclaw, Poland
-
As0010 40044
Poznan, Poland
-
As0010 40045
A Coruña, Spain
-
As0010 40046
Córdoba, Spain
-
As0010 40047
Madrid, Spain
-
As0010 40048
Santiago de Compostela, Spain
-
As0010 40049
Seville, Spain
-
As0010 40050
Istanbul, Turkey (Türkiye)
-
As0010 40051
Izmir, Turkey (Türkiye)
-
As0010 40052
Ankara, Turkey (Türkiye)
-
As0010 40053
Ankara, Turkey (Türkiye)
-
As0010 40054
London, United Kingdom
-
As0010 40055
Norwich, United Kingdom
-
As0010 40056
Leeds, United Kingdom
-
As0010 40057
Edinburgh, United Kingdom
-
As0010 40078
Leipzig, Germany
-
As0010 40080
Szombathely, Hungary
-
As0010 50012
Memphis, Tennessee, 38119-5214, United States
-
As0010 50015
Hagerstown, Maryland, 21740, United States
-
As0010 50016
St Louis, Missouri, 63141, United States
-
As0010 50020
Duncansville, Pennsylvania, 16635, United States
-
As0010 50036
Mesquite, Texas, 75150, United States
-
As0010 50052
Phoenix, Arizona, 85032, United States
-
As0010 50055
Portland, Oregon, 97239-3011, United States
-
As0010 50056
Sarasota, Florida, 34239, United States
-
As0010 50057
Dallas, Texas, 75231, United States
-
As0010 50059
Ormond Beach, Florida, 32174, United States
-
As0010 50060
Upland, California, 91786, United States
-
As0010 50061
Spokane, Washington, 99204, United States
-
As0010 50062
Sun City, Arizona, 85351, United States
-
As0010 50131
Mesa, Arizona, 85210, United States